RedHill Offers Data Showing EnteraGam’s Benefits as Dietary Therapy for IBD Patients

RedHill Offers Data Showing EnteraGam’s Benefits as Dietary Therapy for IBD Patients
RedHill Biopharma says its medical food, EnteraGam, is clinically and economically beneficial for inflammatory bowel disease (IBD) patients with chronic diarrhea. The Israeli company presented EnteraGam on Nov. 7 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, in Glasgow, Scotland. A medical food indicated to help manage diarrhea-predominant irritable bowel syndrome (IBS-D),

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *